Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Schwartz

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|January 6, 2007
Medical education after the Flexner reportJonathan D Schwartz
The New England Journal of Medicine|July 28, 2006
Case 13-2006: a man with a bone mass and lesions in the liverJonathan D Schwartz
The New England Journal of Medicine|April 9, 2002
Nephrectomy for metastatic renal-cell cancerJonathan D Schwartz
The New England Journal of Medicine|December 3, 2010
Diarrhea from ipilimumab in melanomaJonathan D Schwartz
The New England Journal of Medicine|April 18, 2019
Tisagenlecleucel in Diffuse Large B-Cell LymphomaJonathan D Schwartz
Anti-Cancer Drugs|May 29, 2004
Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-I: hepatic arterial embolization and embolization-based therapies in unresectable hepatocellular carcinomaDiane L Reidy, Jonathan D Schwartz
Anti-Cancer Drugs|May 29, 2004
Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinomaJonathan D Schwartz, Andreas S Beutler
The Lancet. Oncology|October 10, 2002
Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trialsJonathan D Schwartz, Myron Schwartz, John Mandeli, et al.
The New England Journal of Medicine|June 29, 2022
Mitapivat versus Placebo for Pyruvate Kinase DeficiencyAmi J Shah, Jonathan D Schwartz, Jose C Segovia
World Neurosurgery|May 6, 2020
Diffuse Midline Gliomas without the H3 K27M Mutation: Surgical Biopsy is Needed to Better our Diagnostic UnderstandingVictor M Lu, Aditya Raghunathan, Jonathan D Schwartz, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|January 6, 2007
Medical education after the Flexner reportJonathan D Schwartz
The New England Journal of Medicine|July 28, 2006
Case 13-2006: a man with a bone mass and lesions in the liverJonathan D Schwartz
The New England Journal of Medicine|April 9, 2002
Nephrectomy for metastatic renal-cell cancerJonathan D Schwartz
The New England Journal of Medicine|December 3, 2010
Diarrhea from ipilimumab in melanomaJonathan D Schwartz
The New England Journal of Medicine|April 18, 2019
Tisagenlecleucel in Diffuse Large B-Cell LymphomaJonathan D Schwartz
Anti-Cancer Drugs|May 29, 2004
Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-I: hepatic arterial embolization and embolization-based therapies in unresectable hepatocellular carcinomaDiane L Reidy, Jonathan D Schwartz
Anti-Cancer Drugs|May 29, 2004
Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinomaJonathan D Schwartz, Andreas S Beutler
The Lancet. Oncology|October 10, 2002
Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trialsJonathan D Schwartz, Myron Schwartz, John Mandeli, et al.
The New England Journal of Medicine|June 29, 2022
Mitapivat versus Placebo for Pyruvate Kinase DeficiencyAmi J Shah, Jonathan D Schwartz, Jose C Segovia
World Neurosurgery|May 6, 2020
Diffuse Midline Gliomas without the H3 K27M Mutation: Surgical Biopsy is Needed to Better our Diagnostic UnderstandingVictor M Lu, Aditya Raghunathan, Jonathan D Schwartz, et al.
Pageof 6